Lymphoma response to chimeric antigen receptor T cell therapy is driven by endogenous tumor-reactive CD8⁺ T cells.

Ziccheddu B, Savid-Frontera C, Saralamma VVG, Gatenbee C, Youssfi AA, Chojnacka M, Menges M, Cuadrado-Delgado L, Durante M, Mullinax J, Reid K, Miranda JA, Corallo S, Merritt E, Sawyer W, Augello A, Newsam AD, Chahar D, Amador C, Spiegel JY, Davila M, Landgren O, Alderuccio JP, Robertson-Tessi M, Atkins R, Usmani S, Jain MD, Anderson ARA, Maura F, Schatz JH, Locke FL

Open source

DOI: 10.64898/2026.10.23.761341
Published: 2026 Oct 27
Container: bioRxiv : the preprint server for biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.10.23.761341,
  title = {Lymphoma response to chimeric antigen receptor T cell therapy is driven by endogenous tumor-reactive CD8⁺ T cells.},
  author = {Ziccheddu B and Savid-Frontera C and Saralamma VVG and Gatenbee C and Youssfi AA and Chojnacka M and Menges M and Cuadrado-Delgado L and Durante M and Mullinax J and Reid K and Miranda JA and Corallo S and Merritt E and Sawyer W and Augello A and Newsam AD and Chahar D and Amador C and Spiegel JY and Davila M and Landgren O and Alderuccio JP and Robertson-Tessi M and Atkins R and Usmani S and Jain MD and Anderson ARA and Maura F and Schatz JH and Locke FL},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.10.23.761341},
  url = {https://doi.org/10.64898/2026.10.23.761341}
}

RIS

TY  - JOUR
TI  - Lymphoma response to chimeric antigen receptor T cell therapy is driven by endogenous tumor-reactive CD8⁺ T cells.
AU  - Ziccheddu B
AU  - Savid-Frontera C
AU  - Saralamma VVG
AU  - Gatenbee C
AU  - Youssfi AA
AU  - Chojnacka M
AU  - Menges M
AU  - Cuadrado-Delgado L
AU  - Durante M
AU  - Mullinax J
AU  - Reid K
AU  - Miranda JA
AU  - Corallo S
AU  - Merritt E
AU  - Sawyer W
AU  - Augello A
AU  - Newsam AD
AU  - Chahar D
AU  - Amador C
AU  - Spiegel JY
AU  - Davila M
AU  - Landgren O
AU  - Alderuccio JP
AU  - Robertson-Tessi M
AU  - Atkins R
AU  - Usmani S
AU  - Jain MD
AU  - Anderson ARA
AU  - Maura F
AU  - Schatz JH
AU  - Locke FL
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.10.23.761341
UR  - https://doi.org/10.64898/2026.10.23.761341
ER  -

APA

B, Z., C, S., VVG, S., C, G., AA, Y., M, C., M, M., L, C., M, D., J, M., K, R., JA, M., S, C., E, M., W, S., A, A., AD, N., D, C., C, A., JY, S., M, D., O, L., JP, A., M, R., R, A., S, U., MD, J., ARA, A., F, M., JH, S., & FL, L. (2026). Lymphoma response to chimeric antigen receptor T cell therapy is driven by endogenous tumor-reactive CD8⁺ T cells.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.10.23.761341

Source records

pubmed · retrieved 2026-11-10T12:26:10.187Z